We are live on ! Find out more
DRIOW

DarioHealth Corp. Warrant

Delisted

DRIOW was delisted on the 4th of March, 2021.

1 hedge funds and large institutions have $18K invested in DarioHealth Corp. Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% less capital invested

Capital invested by funds: $23K → $18K (-$5K)

50% less funds holding

Funds holding: 21 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$191

Top Sellers

Rank Fund Capital Flow
1
WPC
Waters Parkerson & Co
Louisiana
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$17K
UBS Group
2
UBS Group
Switzerland
$1K +$191 +700 +15%
WPC
3
Waters Parkerson & Co
Louisiana
-$5K -20,000 Closed

DRIOW Hedge Fund Activity: Q4 2017 in Review

1 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q4 2017, worth a combined $18K — down 22% from $23K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DRIOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $191. The largest seller was Waters Parkerson & Co, exiting entirely with an estimated $5K sold.

  • 1 institutional investor held DarioHealth Corp. Warrant (DRIOW) as of Q4 2017, down from 2 in Q3 2017.
  • Funds reported $18K of DarioHealth Corp. Warrant stock for Q4 2017, down 22% quarter-over-quarter.
  • 0 funds opened new DarioHealth Corp. Warrant positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest DarioHealth Corp. Warrant buyer in Q4 2017 was UBS Group, an estimated $191 added.
  • The largest DarioHealth Corp. Warrant seller in Q4 2017 was Waters Parkerson & Co, an estimated $5K sold.

Based on aggregated 13F filings for Q4 2017.